HRES 1285
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Bill status
- Status
- In committee
- Sponsor
- Rep. Diana DeGette [D-CO-1]
- Cosponsors
- 50
- Policy area
- Health
- Introduced
- 2026-05-14
- Latest action
- 2026-05-14: Referred to the House Committee on Energy and Commerce.
Committee referrals
Recent actions
- 2026-05-14: Referred to the House Committee on Energy and Commerce.
- 2026-05-14: Submitted in House